BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17519555)

  • 1. Ethanol inhibitory effect on rat kidney brush border aminopeptidases.
    Vlahović P; Cvetković T; Nikolić J; Sokolović D
    Nephron Exp Nephrol; 2007; 106(3):e73-6. PubMed ID: 17519555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle and jejunal protein synthesis in normal and ethanol-treated rats: the effect of the nitric oxide synthase inhibitors, L-omega-nitro-L-arginine methyl ester and N(G)-nitro-L-arginine in vivo.
    Rajendram R; Marway JS; Mantle D; Peters TJ; Preedy VR
    Metabolism; 2003 Apr; 52(4):397-401. PubMed ID: 12701048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat.
    Yang Y; Macdonald GJ; Duggan KA
    Clin Sci (Lond); 2001 Mar; 100(3):319-26. PubMed ID: 11222119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
    Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
    J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The luminal membrane of rat thick limb expresses AT1 receptor and aminopeptidase activities.
    Poumarat JS; Houillier P; Rismondo C; Roques B; Lazar G; Paillard M; Blanchard A
    Kidney Int; 2002 Aug; 62(2):434-45. PubMed ID: 12110004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
    Guzmán-Hernández EA; Villalobos-Molina R; Sánchez-Mendoza MA; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M
    Can J Physiol Pharmacol; 2015 Apr; 93(4):299-308. PubMed ID: 25761067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).
    Ye S; Nosrati S; Campese VM
    J Clin Invest; 1997 Feb; 99(3):540-8. PubMed ID: 9022090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
    Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
    Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthase.
    O'Sullivan SE; Randall MD; Gardiner SM
    J Pharmacol Exp Ther; 2007 May; 321(2):663-72. PubMed ID: 17284670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nitric oxide inhibition on blood pressure depends on rat strain.
    Forster J; Beebe P; Wang H; Wood JG
    J Surg Res; 2001 Apr; 96(2):218-23. PubMed ID: 11266276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.
    Suehiro T; Tsuruya K; Ikeda H; Toyonaga J; Yamada S; Noguchi H; Tokumoto M; Kitazono T
    Endocrinology; 2015 Jul; 156(7):2657-66. PubMed ID: 25872005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
    López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
    Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.